Sales/Maturities of Investments

$10.68B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$10.68Bperiod endingJun 30, 2026

REGN Sales/Maturities of Investments ($61.80M → $10.68B)

Annual Sales/Maturities of Investments

High-resolution chart · PNG

REGN sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Sales/Maturities of Investments — Annual fiscal periods (USD)
Period ending	Sales/Maturities of Investments (USD)
Dec 31, 2025	11,546,200,000
Dec 31, 2024	15,027,300,000
Dec 31, 2023	9,442,200,000
Dec 31, 2022	5,550,500,000
Dec 31, 2021	2,215,300,000
Dec 31, 2020	3,785,000,000
Dec 31, 2019	1,604,200,000
Dec 31, 2018	775,600,000
Dec 31, 2017	544,584,000
Dec 31, 2016	274,456,000
Dec 31, 2015	327,437,000
Dec 31, 2014	476,417,000
Dec 31, 2013	378,146,000
Dec 31, 2012	439,209,000
Dec 31, 2011	426,356,000
Dec 31, 2010	276,601,000
Dec 31, 2009	297,411,000
Dec 31, 2008	646,861,000
Dec 31, 2007	527,169,000
Dec 31, 2006	306,199,000
Dec 31, 2005	223,448,000
Dec 31, 2004	277,909,000
Dec 31, 2003	253,315,000
Dec 31, 2002	215,831,000
Dec 31, 2001	124,189,000
Dec 31, 2000	53,717,000
Dec 31, 1999	83,200,000
Dec 31, 1998	93,500,000
Dec 31, 1997	75,900,000
Dec 31, 1996	38,900,000
Dec 31, 1995	38,800,000
Dec 31, 1994	61,300,000
Dec 31, 1993	68,500,000
Dec 31, 1992	82,800,000
Dec 31, 1991	61,800,000